573 related articles for article (PubMed ID: 28643475)
1. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
Chakraborty S; Dhakshinamurthy GS; Misra SK
J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
[TBL] [Abstract][Full Text] [Related]
2. Spatial-temporal event adaptive characteristics of nanocarrier drug delivery in cancer therapy.
Kong M; Park H; Cheng X; Chen X
J Control Release; 2013 Nov; 172(1):281-291. PubMed ID: 24004884
[TBL] [Abstract][Full Text] [Related]
3. Graphene as multifunctional delivery platform in cancer therapy.
Nejabat M; Charbgoo F; Ramezani M
J Biomed Mater Res A; 2017 Aug; 105(8):2355-2367. PubMed ID: 28371194
[TBL] [Abstract][Full Text] [Related]
4. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
[TBL] [Abstract][Full Text] [Related]
5. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
6. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy.
Zhou Q; Zhang L; Yang T; Wu H
Int J Nanomedicine; 2018; 13():2921-2942. PubMed ID: 29849457
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
Li L; Yang WW; Xu DG
J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
[TBL] [Abstract][Full Text] [Related]
10. Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery.
Zou H; Wang Z; Feng M
J Control Release; 2015 Sep; 214():121-33. PubMed ID: 26208425
[TBL] [Abstract][Full Text] [Related]
11. Smart Drug Delivery Systems in Cancer Therapy.
Unsoy G; Gunduz U
Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
[TBL] [Abstract][Full Text] [Related]
12. Ligand-Installed Nanocarriers toward Precision Therapy.
Mi P; Cabral H; Kataoka K
Adv Mater; 2020 Apr; 32(13):e1902604. PubMed ID: 31353770
[TBL] [Abstract][Full Text] [Related]
13. Use of degradable and nondegradable nanomaterials for controlled release.
Wan WK; Yang L; Padavan DT
Nanomedicine (Lond); 2007 Aug; 2(4):483-509. PubMed ID: 17716133
[TBL] [Abstract][Full Text] [Related]
14. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
[TBL] [Abstract][Full Text] [Related]
15. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
Raj R; Mongia P; Kumar Sahu S; Ram A
Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
[TBL] [Abstract][Full Text] [Related]
16. How are we applying nanogel composites in biomedicine?
Kar M; Molina M; Calderón M
Nanomedicine (Lond); 2017 Jul; 12(14):1627-1630. PubMed ID: 28635377
[No Abstract] [Full Text] [Related]
17. Advances in Nanocarriers for Anticancer Drugs Delivery.
Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
[TBL] [Abstract][Full Text] [Related]
19. Design of multifunctional nanocarriers for delivery of anti-cancer therapy.
Mehra NK; Jain K; Jain NK
Curr Pharm Des; 2015; 21(42):6157-64. PubMed ID: 26503145
[TBL] [Abstract][Full Text] [Related]
20. Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers.
Sharifi S; Caracciolo G; Mahmoudi M
Trends Pharmacol Sci; 2020 Sep; 41(9):641-652. PubMed ID: 32713606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]